The chemical class termed FAM53C Inhibitors encompasses a range of compounds that can modulate the function of FAM53C, a protein known for its role in cell proliferation, growth, and gene regulation. These compounds are characterized by their ability to interact with and influence the cellular pathways and processes in which FAM53C is implicated. The modulation of FAM53C by these compounds is achieved through indirect means, given the absence of direct antagonists. This approach is reflective of the complex nature of targeting proteins like FAM53C, which are integrated into multiple cellular pathways and do not present a conventional active site for direct ligand binding.
The primary mode of action of these compounds involves targeting mechanisms such as cell cycle regulation, gene expression, and pathways implicated in cancer development. By influencing cell cycle progression, these compounds can affect the role of FAM53C in cell proliferation and growth. This includes impacting the processes that control the transition of cells through various phases of the cell cycle, which is a critical aspect of cellular division and growth. Additionally, compounds that affect gene expression can indirectly influence FAM53C's function in regulating chromatin dynamics and transcriptional activity. Given FAM53C's involvement in gene regulation, altering the chromatin structure or modulating the activity of transcription factors can impact FAM53C's role in these processes. Furthermore, in the context of cancer, where alterations in FAM53C expression or function might contribute to disease progression, compounds that target oncogenic pathways can also modulate FAM53C's function. This includes influencing signaling pathways that are crucial for cell growth, survival, and differentiation. The ability of these compounds to modulate FAM53C's function underscores the necessity of understanding the broader cellular context and the network of interactions governing its activity. The development and exploration of FAM53C modulating compounds are part of ongoing research strategies aimed at elucidating the functional roles of FAM53C and investigating ways to influence its activity in various cellular contexts. The capability of these compounds to affect FAM53C highlights not only the complexity of targeting such multifunctional proteins but also the nuanced understanding required to manipulate their activity within the dense web of cellular interactions and processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Could possibly inhibit FAM53C by disrupting cell cycle progression, affecting its role in cell proliferation and growth. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Could possibly inhibit FAM53C by affecting chromatin remodeling and gene regulation, influencing its role in these processes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Could possibly inhibit FAM53C by altering gene expression and chromatin structure, impacting its involvement in gene regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Could possibly inhibit FAM53C by affecting cell growth and proliferation pathways, influencing its role in these processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Could possibly inhibit FAM53C by disrupting signal transduction pathways, affecting its role in cell signaling and cancer pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Could possibly inhibit FAM53C by affecting protein degradation pathways, impacting its stability or turnover. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Could possibly inhibit FAM53C by altering phosphoinositide signaling, impacting its activities in signaling pathways. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Could possibly inhibit FAM53C by disrupting DNA synthesis, affecting its role in cell proliferation and cancer. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Could possibly inhibit FAM53C by intercalating DNA and disrupting topoisomerase-II-mediated DNA repair, affecting its function in cell growth and cancer pathways. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Could possibly inhibit FAM53C by disrupting cell division, affecting its role in cell proliferation and growth. | ||||||